Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.19.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Payments to Noncontrolling Interests $ (17,880,000) $ 0
Cash flows from operating activities:    
Net income 216,464,000 161,599,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 88,775,000 43,544,000
Loss on disposal of property, plant, and equipment 4,866,000 1,979,000
Deferred income taxes (3,157,000) 2,103,000
Stock-based compensation 13,159,000 10,247,000
Changes in operating assets and liabilities:    
Accounts receivable (199,416,000) (125,433,000)
Inventories (198,999,000) (188,544,000)
Prepaid expenses and other current assets (12,596,000) (7,968,000)
Other assets (3,981,000) (9,782,000)
Accounts payable (65,191,000) (14,263,000)
Accrued liabilities 6,497,000 38,193,000
Income taxes payable (11,286,000) (7,200,000)
Increase (Decrease) in Operating Liabilities (39,010,000) 0
Other liabilities 5,716,000 (2,541,000)
Net cash provided by operating activities (198,159,000) (98,066,000)
Cash flows from investing activities:    
Purchases of short-term investments (181,257,000) (426,278,000)
Proceeds from Sale, Maturity and Collection of Short-term Investments 445,501,000 252,727,000
Capital expenditures (104,527,000) (45,189,000)
Proceeds from sale of property, plant, and equipment 0 18,000
Net cash used in investing activities 159,717,000 (218,722,000)
Cash flows from financing activities:    
Proceeds from credit facilities 74,053,000 36,051,000
Repayments on credit facilities (74,053,000) (27,740,000)
Proceeds from issuance of common stock under employee stock plans 17,687,000 16,508,000
Tax payments related to restricted stock unit issuances (5,739,000) (4,221,000)
Payments for Repurchase of Common Stock (116,239,000) (107,222,000)
Cash dividends paid (48,917,000) (46,160,000)
Payments of Ordinary Dividends, Noncontrolling Interest 0 (19,949,000)
Net cash used in financing activities (171,088,000) (152,733,000)
Net effect of exchange rate changes on cash (2,954,000) (7,500,000)
Net increase (decrease) in cash and cash equivalents (212,484,000) (477,021,000)
Cash, cash equivalents and restricted cash, beginning of period 451,795,000 673,166,000
Cash, cash equivalents and restricted cash, end of period 239,311,000 196,145,000
Supplemental disclosures of cash flow information:    
Cash paid during the period for income taxes 73,413,000 47,041,000
Supplemental disclosures of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 11,638,000 $ 7,380,000